1. OP09 TIPS outcomes for refractory ascites: a single centre experience. (6th September 2011) Authors: Macnaughtan, J; Hogan, B; Tritto, G; Mullan, M; Yu, D; Thorburn, D; O'Beirne, J; Jalan, R; Patch, D; Burroughs, A Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP16 Evidence for compartmentalised endotoxaemia and its effect on neutrophil function in the portal circulation in cirrhosis. (16th November 2010) Authors: Macnaughtan, J; Davies, N; Stadlbauer, V; Damink, S Olde; Mookerjee, R; Jalan, R Journal: Gut Issue: Volume 59(2010)Supplement 2 Page Start: A7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P17 TIPS outcomes for Budd–Chiari: a single tertiary centre experience. (6th September 2011) Authors: Macnaughtan, J; Hogan, B; Tritto, G; Mullan, M; Yu, D; Thorburn, D; O'Beirne, J; Jalan, R; Patch, D; Burroughs, A Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PMO-127 Biological effects of oral nanoporous carbon in bile duct ligated rats. (28th May 2012) Authors: Macnaughtan, J; Soeda, J; Mouralidarane, A; Sandeman, S; Howell, C; Kozynchenko, O; Tennison, S; Mikhalovsky, S; Davies, N; Oben, J; Mookerjee, R; Jalan, R Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PMO-128 Effects of oral nanoporous carbon therapy in leptin null mice as a model of non-alcoholic steatohepatitis. (28th May 2012) Authors: Macnaughtan, J; Soeda, J; Mouralidarane, A; Sandeman, S; Howell, C; Milkhalovsky, S; Kozynchenko, O; Tennison, S; Davies, N; Mookerjee, R; Oben, J; Jalan, R Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PTH-095 Oral carbon therapy is associated with a selective modulation of the microbiome in cirrhotic rats which is associated with a significant reduction in inflammatory activation. (22nd June 2015) Authors: Macnaughtan, J; Ranchal, I; Soeda, J; Sawhney, R; Oben, J; Davies, N; Mookerjee, R; Marchesi, J; Cox, J; Jalan, R Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PWE-098 Increase in gut permeability is an early event in cirrhosis and is not associated with bacterial translocation, systemic inflammation or clinical features: a prospective longitudinal study. (22nd June 2015) Authors: Figorilli, F; Macnaughtan, J; Moratalla, A; Mookerjee, RP; Davies, N; Jalan, R Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PWE-267 Urinary TLR4: a novel biomarker to identify patients with acute kidney injury in patients with acute on chronic liver failure. (28th May 2012) Authors: Shah, N; Mohammed, F; Jover-Cobos, M; Macnaughtan, J; Davies, N A; Moreau, R; Paradis, V; Moore, K; Mookerjee, R P; Jalan, R Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗